Single pancreatic endocrine cells (PEC) have been demonstrated to restore normoglycemia when transplanted intracerebrally in diabetic rat recipients across a major histocompatibility barrier without immunosuppression. Twelve out of twelve transplants of purified PEC have achieved long-term survival of over 176 days. This approach would provide a model to identify the specific cell(s) as inducer of graft rejection and an opportunity for transplantation study in spontaneous diabetic BB rats and larger diabetic animal models. DIABETES 32:1185-1187, December 1983. T ransplanted pancreatic islet tissue has been observed to restore normoglycemia and prevent secondary complications in the recipient diabetic animals. Allotransplantation of pancreatic islets for the treatment of diabetes mellitus is limited by immune rejection. The present hypothesis considers that certain cellular elements within the donor islets other than the endocrine cells, e.g., passenger leukocytes, are responsible for the induction of graft rejection. Various manipulations of pancreatic islets before transplantation have only been able to achieve varying degrees of success in the prolongation of allograft survival, 1 one approach being the modification of islet immunogenicity by in vitro culture before transplantation. 23 However, the duration of prolonged graft survival was variable and a better result was achieved in those recipients that received short-term immunosuppression. A second approach was immunoisolation by means of a membrane barrier, which can isolate the tissue graft from the host immune system. 4 Though theoretically sound, the use of an artificial semipermeable membrane has encountered many practical problems.
T ransplanted pancreatic islet tissue has been observed to restore normoglycemia and prevent secondary complications in the recipient diabetic animals. Allotransplantation of pancreatic islets for the treatment of diabetes mellitus is limited by immune rejection. The present hypothesis considers that certain cellular elements within the donor islets other than the endocrine cells, e.g., passenger leukocytes, are responsible for the induction of graft rejection. Various manipulations of pancreatic islets before transplantation have only been able to achieve varying degrees of success in the prolongation of allograft survival, 1 one approach being the modification of islet immunogenicity by in vitro culture before transplantation. 23 However, the duration of prolonged graft survival was variable and a better result was achieved in those recipients that received short-term immunosuppression. A second approach was immunoisolation by means of a membrane barrier, which can isolate the tissue graft from the host immune system. 4 Though theoretically sound, the use of an artificial semipermeable membrane has encountered many practical problems. 1 However, these problems probably can be ob-viated by employing a natural semipermeable membrane, the blood-brain barrier, which permits ready transmembrane passage of O 2 and CO 2 and diffusion of glucose and insulin across the membrane barrier while it limits the passage of antibody and restricts lymphocytic infiltration. 56 Reports of functional allograft and xenograft of neural and endocrine tissues in the brain also suggest that brain tissue can provide a suitable environment for the survival of transplanted PEC.
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In this article we report the successful allotransplantation of purified PEC in the brain of diabetic rat recipients across a major histocompatibility barrier without immunosuppression.
MATERIALS AND METHODS
Male rats of the inbred Lewis (Le; AgB 1/1) strain weighing 350-500 g, were selected as donors of pancreatic islets and of the ACI (AgB 4/4) strain as streptozotocin-induced (55 mg/kg i.v.) diabetic recipients. Pancreatic tissue was digested with collagenase and the islets were handpicked under a dissection microscope. Contaminating acinar tissues and blood vessels were removed from the islets by the single-layer Hypaque-Ficoll (H-F) separation technique. 9 Clean islets collected at the interface were either cultured overnight at 26°C before transplantation or immediately dissociated into single cell suspension. For dissociation into single cells, islets were suspended and resuspended every minute in 1 ml 0.04% EDTA in Ca 2+ -Mg 2+ -free Hanks' balanced salt solution (HBSS), pH 7.2, at 25°C for 5 min. One milliliter of 0.02% VMF trypsin (Worthington, Freehold, New Jersey) solution in HBSS at 37°C was added to the islets. 10 After 2 min of incubation, the islets were dispersed gently with a 19-gauge needle until the completion of their dissociation as observed under an inverted microscope. The cells were filtered through a sterile 66-mesh nylon screen in a 13-mm Millipore holder to remove cell clumps. Single cell suspension in 1 ml HBSS was subsequently layered on top of 4 ml single layer H-F solution with a specific gravity of 1.080. Centrifugation was carried out at 22°C for 8 min at 800 x g after which cells at the interface were collected. Cells from a quantity of 1500 islets were suspended in 15 ml of culture medium (M199 containing 15% fetal calf serum) and dis- pensed into a 100 x 20-mm plastic dish and cultured in a humidified 5% CO 2 incubator at 26°C overnight. Viable PEC collected at the interface of H-F gradient after centrifugation for 8 min at 800 x g were subsequently collected for transplantation study.
ACI diabetic rats were divided into four groups: (1) shamoperated controls (N = 6), (2) intraportal transplant of whole islets (N = 8), (3) intracerebrai transplant of whole islets (N = 6), and (4) intracerebrai transplant of PEC (N = 12). Fifteen hundred whole islets of 2-3 x 10 6 viable PEC suspended in 50 |xl vol were stereotaxically injected with a 26-gauge needle into the brain of the diabetic recipient through a burr hole 3.8 mm in depth, 0.5 mm posterior to bregma, and 1.5-2.0 mm lateral to the rostrocaudal axis. 11 Identical surgical procedures were repeated with the sham-operated control animals, which received an injection of physiologic saline. The plasma glucose and 24-h urine volume for each recipient rat were assessed daily after transplantation. In addition, 24-h serial blood glucoses were performed on these rats at around 4 wk after successful transplantation. Rejection was considered to have occurred when the blood glucose level after normalization of the diabetic state exceeded 200 mg/dl for 2 successive days. To determine the location and morphology of the transplanted cells, one recipient rat with functional aliogeneic PEC for 2 wk was killed and the brain tissue was fixed in situ with 10% phosphatebuffered formalin, sectioned, and stained with hematoxylineosin and immunoperoxidase stain (Immunlok, Inc., Carpentia, California) and prepared for microscopic examination. Table 1 shows the allograft survival time after intracerebrai or intraportal transplantation. All the intraportal transplants were rejected within 6 days. Although both types of intracerebrai allografts have prolonged survival, all the PEC transplants remained functional, whereas three of six whole islet transplants were rejected. Figure 1 shows that the transplanted PEC normalized the blood glucose levels in all the aliogeneic diabetic recipients within 4 days after transplantation and maintained the normoglycemic state throughout the period of observation. The sham-operated rats sustained their hyperglycemia with gradual deterioration of the diabetic state. Figure 2 demonstrates the normal pattern of 24-h serial blood glucose in all the aliogeneic recipients of PEC.
RESULTS
Histologic examination revealed grafted cells with normal appearance in the subarachnoid space as well as the site immediately adjacent to the lateral ventricle of a recipient rat with functional aliogeneic PEC for 2 wk. There is no evidence of lymphocytic infiltration or inflammatory reaction around the grafts. The presence of insulin granules in the endocrine cells is confirmed with immunoperoxidase stain.
DISCUSSION
The present study demonstrates that the brain has provided a hospitable environment for the survival and function of the grafted PEC and that single endocrine cell suspension of pancreatic islet is functional in vivo in maintaining blood glucose homeostasis in the diabetic recipient rat.
In an earlier study we have observed that intraportal allografts of pseudoislets (Le-» ACI) formed by aggregation of purified PEC had only marginally longer graft survival time than fresh and cultured (at 37°C) whole islets. 12 Prolonged survival of intracerebrally transplanted purified PEC or whole islets observed in this study would confirm that the brain is an immunoprivileged site. Despite this, the blood-brain barrier is not absolute and graft rejection can occur if antigenic dosage is sufficiently high as seen in our whole islet transplants and also in the recent observation that allogeneic fetal rat islets, contaminated with lymph nodes, failed to correct the diabetic state of recipients after intraventricular transplantation. 13 Consistent long-term survival of islet allograft can be achieved without immunosuppression when the combination of purified PEC as graft and brain as transplantation site was used. Further studies with intracerebral transplantation of purified PEC suspensions plus various known cell types within the islet would make it possible to identify the specific inducer of graft rejection. This approach can be extended to the study of allotransplantation in spontaneous diabetic BB rats and xenotransplantation in larger diabetic animal models.
